The comparative study of the change of blood sugar consentration with feeding by "Inslow(Meiji Co., Ltd.)" or contral formula after surgery for gastric cancer who are Diabetes Mellitus or glucose intolerance.

The comparative study of the change of blood sugar consentration with feeding by "Inslow(Meiji Co., Ltd.)" or contral formula after surgery for gastric cancer who are Diabetes Mellitus or glucose intolerance. - The change of blood sugar consentration with feeding by "Inslow(Meiji Co., Ltd.)" after surgery for gastric cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005807

Enrollment

Registered

2011-07-01

Start date

2011-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients who are planed the surgery to gastric cancer with diabetes mellitus or glucose intolerance as 5.9 and over 7.5 and less in HbA1c.

Interventions

a a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a

Exclusion criteria

Exclusion criteria: a

Design outcomes

Primary

Measure	Time frame
1,5-AG	—

Countries

Japan

Contacts

Public ContactNaohiro Washizawa

Toho University Medical Center Omori Hospital Nutrition Therapy Center

washi@med.toho-u.ac.jp0337624151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

The comparative study of the change of blood sugar consentration with feeding by &quot;Inslow(Meiji Co., Ltd.)&quot; or contral formula after surgery for gastric cancer who are Diabetes Mellitus or glucose intolerance.